Application Note
IsoPlexis Proteomic Product Suite for Cancer Immunology
IsoPlexis’ functional proteomics reveals unique secretomic signatures and insights into Cancer Immunology
Your Data is Secure
We will always keep your personal information safe and not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.
You may unsubscribe and update your email subscription at any time.
In this Application Note we discuss:
-
Understanding cancer cell communication to infer a strategy to inhibit tumor cell metastasis
-
Understanding inhibitory mechanism of monocytes toward immune suppression in Follicular Lymphoma (FL)
-
Using mechanisms of immune persistence in solid tumor indications
-
Resolving tumor heterogeneity to reveal independent trajectories of drug tolerance
IsoPlexis Proteomic Product Suite for Cancer Immunology
IsoPlexis’ functional proteomics reveals unique secretomic signatures and insights into Cancer Immunology
